These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 23507288
1. Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage. García-Aparicio L, Rodo J, Palazon P, Martín O, Blázquez-Gómez E, Manzanares A, García-Smith N, Bejarano M, de Haro I, Ribó JM. J Pediatr Urol; 2013 Aug; 9(4):493-7. PubMed ID: 23507288 [Abstract] [Full Text] [Related]
2. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. Kirsch AJ, Perez-Brayfield MR, Scherz HC. J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692 [Abstract] [Full Text] [Related]
15. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid. Puri P, Mohanan N, Menezes M, Colhoun E. J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016 [Abstract] [Full Text] [Related]
16. Endoscopic treatment for vesicoureteral reflux: how important is technique? Watters ST, Sung J, Skoog SJ. J Pediatr Urol; 2013 Dec; 9(6 Pt B):1192-7. PubMed ID: 23769202 [Abstract] [Full Text] [Related]
18. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux. Taşkinlar H, Avlan D, Bahadir GB, Delibaş A, Nayci A. Int Braz J Urol; 2016 Dec; 42(3):514-20. PubMed ID: 27286115 [Abstract] [Full Text] [Related]